BMC rejects all nine vaccine bids, in talk with Dr Reddy's for Sputnik jab

DRL has shown willingness to provide a limited quantity of the Russian shot to the civic body in June under a pilot programme

coronavirus vaccine, gst, gst on vaccine, covid-19
DRL has shown willingness to provide a limited quantity of Russian origin Sputnik vaccine to the BMC in June under a pilot programme, the civic body said in a statement today.
Aneesh Phadnis Mumbai
1 min read Last Updated : Jun 04 2021 | 7:55 PM IST
The BrihanMumbai Municipal Corporation has initiated discussion with Dr Reddy’s Laboratories (DRL) for procurement of Sputnik jabs and has rejected all the nine bids for supply of Covid-19 vaccines after the bidders failed to submit required documents.

DRL has shown willingness to provide a limited quantity of Russian origin Sputnik vaccine to the BMC in June under a pilot programme, the civic body said in a statement today. The corporation will also examine cold chain requirements for Sputnik doses upon confirmation of supplies.

The BMC had invited an expression of ìnterest for ten million doses in May and it received eight offers for supplying Sputnik vaccine and one offer for Pfizer and Astra Zeneca vaccines. After extending the bid submission date twice, the Mumbai civic body decided to reject all offers today. The BMC said none of suppliers furnished required documents to support the offers.

The BMC has also asked DRL about supplying a larger question of doses in July and August and further discussion will be held in next 8-10 days, it said.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusBMCCoronavirus VaccineDr Reddy's Laboratories

Next Story